# Pinnacle West Capital Corp: financial statements, quarterly

PNW · NYSE · CIK 764622 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pnw.md) · [Financials](/companies/pnw/financials.md) · [Filings](/companies/pnw/filings.md) · [Insiders](/companies/pnw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pnw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,638](/filings/0000764622-24-000079.md) | [992 d](/filings/0000764622-26-000011.md) | [952](/filings/0000764622-25-000047.md) | [1,309](/filings/0000764622-25-000072.md) | [1,769](/filings/0000764622-25-000087.md) | [1,095 d](/filings/0000764622-26-000011.md) | [1,032](/filings/0000764622-26-000025.md) | [1,359](/filings/0000764622-26-000041.md) | [1,821](/filings/0000764622-25-000087.md) | [1,128 d](/filings/0000764622-26-000011.md) | [1,150](/filings/0000764622-26-000025.md) | [1,456](/filings/0000764622-26-000041.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [516](/filings/0000764622-24-000079.md) | [74.4 d](/filings/0000764622-26-000011.md) | [66.8](/filings/0000764622-25-000047.md) | [314](/filings/0000764622-25-000072.md) | [547](/filings/0000764622-25-000087.md) | [84.5 d](/filings/0000764622-26-000011.md) | [57.2](/filings/0000764622-26-000025.md) | [308](/filings/0000764622-26-000041.md) | [582](/filings/0000764622-25-000087.md) | [121 d](/filings/0000764622-26-000011.md) | [131](/filings/0000764622-26-000025.md) | [306](/filings/0000764622-26-000041.md) |
| Interest expense | $m | [87.8](/filings/0000764622-23-000103.md) | [86.6 d](/filings/0000764622-24-000016.md) | [86.6](/filings/0000764622-24-000044.md) | [97.9](/filings/0000764622-25-000072.md) | [98.0](/filings/0000764622-25-000087.md) | [95.0 d](/filings/0000764622-26-000011.md) | [94.8](/filings/0000764622-26-000025.md) | [102](/filings/0000764622-26-000041.md) | [111](/filings/0000764622-25-000087.md) | [114 d](/filings/0000764622-26-000011.md) | [116](/filings/0000764622-26-000025.md) | [122](/filings/0000764622-26-000041.md) |
| Income tax | $m | [57.0](/filings/0000764622-24-000079.md) | [2.8 d](/filings/0000764622-26-000011.md) | [3.9](/filings/0000764622-25-000047.md) | [32.4](/filings/0000764622-25-000072.md) | [74.2](/filings/0000764622-25-000087.md) | [(0.0) d](/filings/0000764622-26-000011.md) | [(6.2)](/filings/0000764622-26-000025.md) | [35.0](/filings/0000764622-26-000041.md) | [77.9](/filings/0000764622-25-000087.md) | [(0.0) d](/filings/0000764622-26-000011.md) | [1.2](/filings/0000764622-26-000025.md) | [31.3](/filings/0000764622-26-000041.md) |
| Net income | $m | [403](/filings/0000764622-24-000079.md) | [4.3 d](/filings/0000764622-26-000011.md) | [21.2](/filings/0000764622-25-000047.md) | [208](/filings/0000764622-25-000072.md) | [399](/filings/0000764622-25-000087.md) | [(2.5) d](/filings/0000764622-26-000011.md) | [(0.3)](/filings/0000764622-26-000025.md) | [197](/filings/0000764622-26-000041.md) | [418](/filings/0000764622-25-000087.md) | [17.6 d](/filings/0000764622-26-000011.md) | [35.1](/filings/0000764622-26-000025.md) | [181](/filings/0000764622-26-000041.md) |
| Diluted EPS | $ per share | [3.50](/filings/0000764622-24-000079.md) | not reported | [0.15](/filings/0000764622-25-000047.md) | [1.76](/filings/0000764622-25-000072.md) | [3.37](/filings/0000764622-25-000087.md) | not reported | [(0.04)](/filings/0000764622-26-000025.md) | [1.58](/filings/0000764622-26-000041.md) | [3.39](/filings/0000764622-25-000087.md) | not reported | [0.27](/filings/0000764622-26-000025.md) | [1.43](/filings/0000764622-26-000041.md) |
| Basic EPS | $ per share | [3.51](/filings/0000764622-24-000079.md) | not reported | [0.15](/filings/0000764622-25-000047.md) | [1.79](/filings/0000764622-25-000072.md) | [3.47](/filings/0000764622-25-000087.md) | not reported | [(0.04)](/filings/0000764622-26-000025.md) | [1.61](/filings/0000764622-26-000041.md) | [3.45](/filings/0000764622-25-000087.md) | not reported | [0.27](/filings/0000764622-26-000025.md) | [1.47](/filings/0000764622-26-000041.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000764622-23-000103.md) | [0.0](/filings/0000764622-25-000023.md) | [0.0](/filings/0000764622-24-000044.md) | [0.0](/filings/0000764622-24-000065.md) | [0.0](/filings/0000764622-24-000079.md) | [0.0](/filings/0000764622-26-000011.md) | [0.0](/filings/0000764622-25-000047.md) | [0.0](/filings/0000764622-25-000072.md) | [0.0](/filings/0000764622-25-000087.md) | [0.0](/filings/0000764622-26-000041.md) | [0.0](/filings/0000764622-26-000025.md) | [0.0](/filings/0000764622-26-000041.md) |
| Current assets | $bn | [2.2](/filings/0000764622-23-000103.md) | [1.9](/filings/0000764622-25-000023.md) | [1.8](/filings/0000764622-24-000044.md) | [2.0](/filings/0000764622-24-000065.md) | [2.3](/filings/0000764622-24-000079.md) | [1.7](/filings/0000764622-26-000011.md) | [1.6](/filings/0000764622-25-000047.md) | [1.8](/filings/0000764622-25-000072.md) | [2.0](/filings/0000764622-25-000087.md) | [1.7](/filings/0000764622-26-000041.md) | [1.6](/filings/0000764622-26-000025.md) | [2.0](/filings/0000764622-26-000041.md) |
| Total assets | $bn | [24.4](/filings/0000764622-23-000103.md) | [24.7](/filings/0000764622-25-000023.md) | [24.8](/filings/0000764622-24-000044.md) | [25.7](/filings/0000764622-24-000065.md) | [26.3](/filings/0000764622-24-000079.md) | [26.1](/filings/0000764622-26-000011.md) | [27.2](/filings/0000764622-25-000047.md) | [29.2](/filings/0000764622-25-000072.md) | [29.9](/filings/0000764622-25-000087.md) | [30.0](/filings/0000764622-26-000041.md) | [30.7](/filings/0000764622-26-000025.md) | [32.6](/filings/0000764622-26-000041.md) |
| Current liabilities | $bn | [2.0](/filings/0000764622-23-000103.md) | [2.9](/filings/0000764622-25-000023.md) | [3.1](/filings/0000764622-24-000044.md) | [3.1](/filings/0000764622-24-000065.md) | [3.2](/filings/0000764622-24-000079.md) | [2.8](/filings/0000764622-26-000011.md) | [3.2](/filings/0000764622-25-000047.md) | [3.4](/filings/0000764622-25-000072.md) | [3.0](/filings/0000764622-25-000087.md) | [3.2](/filings/0000764622-26-000041.md) | [2.7](/filings/0000764622-26-000025.md) | [3.4](/filings/0000764622-26-000041.md) |
| Long-term debt | $bn | [8.2](/filings/0000764622-23-000103.md) | [7.5](/filings/0000764622-25-000023.md) | [7.5](/filings/0000764622-24-000044.md) | [8.1](/filings/0000764622-24-000065.md) | [8.1](/filings/0000764622-24-000079.md) | [8.1](/filings/0000764622-26-000011.md) | [8.1](/filings/0000764622-25-000047.md) | [8.5](/filings/0000764622-25-000072.md) | [9.2](/filings/0000764622-25-000087.md) | [9.2](/filings/0000764622-26-000041.md) | [9.8](/filings/0000764622-26-000025.md) | [9.8](/filings/0000764622-26-000041.md) |
| Current portion of debt | $bn | not reported | [0.9](/filings/0000764622-25-000023.md) | not reported | not reported | not reported | [0.8](/filings/0000764622-26-000011.md) | [0.8](/filings/0000764622-25-000047.md) | [0.4](/filings/0000764622-25-000072.md) | [0.6](/filings/0000764622-25-000087.md) | [0.6](/filings/0000764622-26-000041.md) | [0.6](/filings/0000764622-26-000025.md) | [0.8](/filings/0000764622-26-000041.md) |
| Short-term borrowings | $bn | [0.4](/filings/0000764622-23-000103.md) | [0.6](/filings/0000764622-25-000023.md) | [0.8](/filings/0000764622-24-000044.md) | [0.5](/filings/0000764622-24-000065.md) | [0.6](/filings/0000764622-24-000079.md) | [0.6](/filings/0000764622-26-000011.md) | [0.9](/filings/0000764622-25-000047.md) | [1.4](/filings/0000764622-25-000072.md) | [0.7](/filings/0000764622-25-000087.md) | [0.8](/filings/0000764622-26-000041.md) | [0.6](/filings/0000764622-26-000025.md) | [0.8](/filings/0000764622-26-000041.md) |
| Shareholders' equity | $bn | [6.4](/filings/0000764622-23-000103.md) | [6.2](/filings/0000764622-25-000023.md) | [6.2](/filings/0000764622-24-000044.md) | [6.2](/filings/0000764622-24-000065.md) | [6.6](/filings/0000764622-24-000079.md) | [6.8](/filings/0000764622-26-000011.md) | [6.7](/filings/0000764622-25-000047.md) | [6.7](/filings/0000764622-25-000072.md) | [7.2](/filings/0000764622-25-000087.md) | [7.0](/filings/0000764622-26-000041.md) | [7.1](/filings/0000764622-26-000025.md) | [7.0](/filings/0000764622-26-000041.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [396 d](/filings/0000764622-24-000079.md) | [374 d](/filings/0000764622-26-000011.md) | [347](/filings/0000764622-25-000047.md) | [190 d](/filings/0000764622-25-000072.md) | [633 d](/filings/0000764622-25-000087.md) | [439 d](/filings/0000764622-26-000011.md) | [402](/filings/0000764622-26-000025.md) | [261 d](/filings/0000764622-26-000041.md) | [665 d](/filings/0000764622-25-000087.md) | [477 d](/filings/0000764622-26-000011.md) | [235](/filings/0000764622-26-000025.md) | [394 d](/filings/0000764622-26-000041.md) |
| Capital expenditure | $m | [396 d](/filings/0000764622-24-000079.md) | [532 d](/filings/0000764622-26-000011.md) | [518](/filings/0000764622-25-000047.md) | [534 d](/filings/0000764622-25-000072.md) | [666 d](/filings/0000764622-25-000087.md) | [532 d](/filings/0000764622-26-000011.md) | [623](/filings/0000764622-26-000025.md) | [710 d](/filings/0000764622-26-000041.md) | [623 d](/filings/0000764622-25-000087.md) | [670 d](/filings/0000764622-26-000011.md) | [628](/filings/0000764622-26-000025.md) | [729 d](/filings/0000764622-26-000041.md) |
| Dividends paid | $m | [96.2 d](/filings/0000764622-24-000079.md) | [98.0 d](/filings/0000764622-26-000011.md) | [98.1](/filings/0000764622-25-000047.md) | [98.2 d](/filings/0000764622-25-000072.md) | [98.3 d](/filings/0000764622-25-000087.md) | [100 d](/filings/0000764622-26-000011.md) | [105](/filings/0000764622-26-000025.md) | [105 d](/filings/0000764622-26-000041.md) | [105 d](/filings/0000764622-25-000087.md) | [107 d](/filings/0000764622-26-000011.md) | [108](/filings/0000764622-26-000025.md) | [110 d](/filings/0000764622-26-000041.md) |
| Share repurchases | $m | [(0.4) d](/filings/0000764622-24-000079.md) | [2.4 d](/filings/0000764622-25-000023.md) | not reported | not reported | [(0.4) d](/filings/0000764622-25-000087.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [113](/filings/0000764622-23-000103.md) | [113](/filings/0000764622-24-000044.md) | [114](/filings/0000764622-24-000065.md) | [114](/filings/0000764622-24-000079.md) | [114](/filings/0000764622-25-000047.md) | [116](/filings/0000764622-25-000072.md) | [117](/filings/0000764622-25-000087.md) | [120](/filings/0000764622-26-000025.md) | [122](/filings/0000764622-26-000041.md) | [122](/filings/0000764622-25-000087.md) | [124](/filings/0000764622-26-000025.md) | [124](/filings/0000764622-26-000041.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 121,197,234 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0000764622-26-000041.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.